SNORD61: A Nucleotide-Binding Protein Regulating Cellular Processes

Target Name: SNORD61

NCBI ID: G26787

SNORD61

Other Name(s): HBII-342 | Small nucleolar RNA, C/D box 61 | U61 | RNU61 | small nucleolar RNA, C/D box 61

SNORD61: A Nucleotide-Binding Protein Regulating Cellular Processes

SNORD61 (HBII-342) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of RNA-binding proteins, known as Nucleotide-binding proteins (NBPs), and is characterized by the presence of a nucleotide-binding domain.

SNORD61 is expressed in a variety of tissues and organs, including the brain, heart, and kidneys, and is involved in the regulation of various cellular processes that are important for maintaining cellular homeostasis. It has been shown to play a role in the regulation of gene expression, DNA replication, and cell division, among other processes.

One of the unique features of SNORD61 is its ability to interact with specific nucleotides in order to regulate the activity of other proteins. This interaction with nucleotides allows SNORD61 to act as a drug target, or biomarker, by modulating the activity of target proteins. The specific nucleotides with which SNORD61 interacts can vary depending on the cell type and the context in which it is expressed.

SNORD61 has been shown to interact with several different nucleotides, including GTP, ATP, and UTP. These interactions can modulate the activity of other proteins, including transcription factors, which are responsible for regulating gene expression. By interacting with these proteins, SNORD61 can regulate the activity of target genes, thereby influencing the expression of the genes that are important for maintaining cellular homeostasis.

Another mechanism by which SNORD61 can modulate cellular behavior is through its role in the regulation of DNA replication. DNA replication is a critical process for the growth and development of all living organisms, and it is closely monitored by various proteins that ensure that the copy of the DNA is made accurately and completely. SNORD61 has been shown to play a role in the regulation of DNA replication by interacting with the enzyme responsible for the initiation of DNA replication, called DNA polymerase.

SNORD61 can also interact with other proteins that are involved in the regulation of cellular processes that are important for maintaining cellular homeostasis. For example, it has been shown to interact with the protein kinase A1 (PKA), which is involved in the regulation of cellular signaling pathways that are important for cell survival. This interaction between SNORD61 and PKA can modulate the activity of PKA, which in turn can influence the activity of other proteins involved in cellular signaling pathways.

In conclusion, SNORD61 is a protein that is involved in the regulation of various cellular processes that are important for maintaining cellular homeostasis. Its ability to interact with specific nucleotides allows it to act as a drug target or biomarker by modulating the activity of other proteins. The specific mechanisms by which SNORD61 modulates cellular behavior can vary depending on the cell type and the context in which it is expressed, but its role in the regulation of DNA replication and cellular signaling pathways is well established. Further research is needed to fully understand the mechanisms by which SNORD61 functions as a drug target or biomarker.

Protein Name: Small Nucleolar RNA, C/D Box 61

The "SNORD61 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD61 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets